Assessment of Esophageal Epithelium Integrity With Use of a Novel Mucosal Impedance Device
NCT ID: NCT03103789
Last Updated: 2025-05-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
75 participants
OBSERVATIONAL
2014-04-29
2026-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Esophageal Monitoring Device for Assessing Mucosal Impedance
NCT01556919
Assessment of Esophageal Epithelium Integrity With Mucosal Impedance
NCT02318862
[Impedance Measurement for Non-Erosive Reflux Disease
NCT02997527
Mucosal Impedance in Pediatric Population
NCT02320981
Biology in Patients With Reflux Esophagitis
NCT01194323
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Those participants who are diagnosed with Grade C or D esophagitis at the initial visit will return for a follow-up visit after treatment with proton pump inhibitor (PPI) therapy to determine whether or not esophagitis has healed as part of their standard of care. If no esophagitis is detected at the follow-up EGD, we will gather one final comparison MI reading during this visit. If esophagitis is still present, follow-up MI will not be performed.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
GERD patients
Patients who are undergoing standard of care EGD with or without BRAVO pH capsule placement and have been diagnosed with GERD will have mucosal impedance measured by single catheter and balloon assembly.
single catheter mucosal impedance testing
balloon assembly mucosal impedance testing
control
Patients who are undergoing standard of care EGD with or without BRAVO pH capsule placement will have mucosal impedance measured by single catheter and balloon assembly.
single catheter mucosal impedance testing
balloon assembly mucosal impedance testing
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
single catheter mucosal impedance testing
balloon assembly mucosal impedance testing
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients unable to give informed consent
* Use of acid suppressive therapy within last 10 days
* Known history of Barrett's esophagus or gastric surgery, other than non-functioning (slipped) Nissen fundoplication
18 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sandhill Scientific
INDUSTRY
Vanderbilt University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Michael Vaezi
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael Vaezi, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Vanderbilt University Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Vanderbilt University Medical Center Endoscopy Laboratory
Nashville, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Patel DA, Higginbotham T, Slaughter JC, Aslam M, Yuksel E, Katzka D, Gyawali CP, Mashi M, Pandolfino J, Vaezi MF. Development and Validation of a Mucosal Impedance Contour Analysis System to Distinguish Esophageal Disorders. Gastroenterology. 2019 May;156(6):1617-1626.e1. doi: 10.1053/j.gastro.2019.01.253. Epub 2019 Jan 31.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
140470
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.